The COVIDome Explorer researcher portal

Kelly D. Sullivan(University of Colorado Anschutz Medical Campus), Matthew D. Galbraith(University of Colorado Anschutz Medical Campus), Kohl T. Kinning(University of Colorado Anschutz Medical Campus), Kyle W. Bartsch(University of Colorado Anschutz Medical Campus), Nik Levinsky(University of Colorado Anschutz Medical Campus), Paula Araya(University of Colorado Anschutz Medical Campus), Keith P. Smith(University of Colorado Anschutz Medical Campus), Ross E. Granrath(University of Colorado Anschutz Medical Campus), Jessica R. Shaw(University of Colorado Anschutz Medical Campus), Ryan M. Baxter(University of Colorado Anschutz Medical Campus), Kimberly R. Jordan(University of Colorado Anschutz Medical Campus), Seth Russell(University of Colorado Anschutz Medical Campus), Monika Ewa Dzieciatkowska(University of Colorado Anschutz Medical Campus), Julie Ann Reisz(University of Colorado Anschutz Medical Campus), Fabia Gamboni(University of Colorado Anschutz Medical Campus), Francesca Cendali(University of Colorado Anschutz Medical Campus), Tusharkanti Ghosh(Colorado School of Public Health), Andrew A. Monte(University of Colorado Anschutz Medical Campus), Tellen D. Bennett(University of Colorado Anschutz Medical Campus), Michael G Miller(University of Colorado Anschutz Medical Campus), Elena W.Y. Hsieh(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Joaquı́n M. Espinosa(University of Colorado Anschutz Medical Campus)
Cell Reports
July 28, 2021
10.1016/j.celrep.2021.109527
Cited by 47Open Access
Full Text

Abstract

COVID-19 pathology involves dysregulation of diverse molecular, cellular, and physiological processes. To expedite integrated and collaborative COVID-19 research, we completed multi-omics analysis of hospitalized COVID-19 patients, including matched analysis of the whole-blood transcriptome, plasma proteomics with two complementary platforms, cytokine profiling, plasma and red blood cell metabolomics, deep immune cell phenotyping by mass cytometry, and clinical data annotation. We refer to this multidimensional dataset as the COVIDome. We then created the COVIDome Explorer, an online researcher portal where the data can be analyzed and visualized in real time. We illustrate herein the use of the COVIDome dataset through a multi-omics analysis of biosignatures associated with C-reactive protein (CRP), an established marker of poor prognosis in COVID-19, revealing associations between CRP levels and damage-associated molecular patterns, depletion of protective serpins, and mitochondrial metabolism dysregulation. We expect that the COVIDome Explorer will rapidly accelerate data sharing, hypothesis testing, and discoveries worldwide.

Related Papers

No related papers found

Powered by citation graph analysis